Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Senate, October 9, 2025 -- The committee on Senate Ways and Means, to whom was referred the Senate Bill relative to menstrual product ingredient disclosure (Senate, No. 1483),- reports, recommending that the same ought to pass with an amendment substituting a new draft with the same title (Senate, No. 2641).
Introduced
Oct 9, 2025
Last Action
Oct 20, 2025
Session
MA 194th
Sponsors
1 primary · 17 co
Read; and referred to the committee on House Ways and Means
Substituted as a new draft for S1483
Ordered to a third reading
Read third
Passed to be engrossed -see Roll Call #73 (Yeas 39 to Nays 0)
Recommended new draft for S1483
Order relative to subject matter adopted
Placed in the Orders of the Day for Thursday, October 16, 2025
Reported form the committee on Senate Ways and Means
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
Read; and referred to the committee on House Ways and Means
Senate Committee on Ways and Means
Pavel M. Payano
Joanne M. Comerford
Rebecca L. Rausch
John F. Keenan
Jason M. Lewis
Patrick M. O'Connor
James B. Eldridge
Barry R. Finegold
Patricia D. Jehlen
Sal N. DiDomenico
Bruce E. Tarr
Thomas M. Stanley
Michael D. Brady
Jacob R. Oliveira